View More Recent Stories
-
Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology
-
Modular Medical (MODD) Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform
-
Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform
-
Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024
-
Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump
-
Modular Medical (MODD) Announces FDA Clearance of the MODD1 Insulin Pump
-
Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
-
Modular Medical inc. (MODD) PT Raised to $8 at Benchmark
-
Modular Medical inc. (MODD) PT Raised to $8 at Benchmark
-
Registration is Now Open for Tribe Public’s Webinar Event "Diabetes Care Innovator Modular Medical Takes Next Steps" Featuring Modular Medical CEO on Friday, August 9, 2024
-
Modular Medical (MODD) Initiates Transfer of Manufacturing Operations to Phillips Medisize
-
Modular Medical Initiates Transfer of Manufacturing Operations to Phillips Medisize
-
Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform

